The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
|Articles|September 2, 2015
- Pharmaceutical Technology-09-02-2015
- Volume 39
- Issue 9
Pharmaceutical Technology, September 2015 Issue (PDF)
Click the title above to open the Pharmaceutical Technology September 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 11 years ago
Generating Savings from Room Declassificationabout 11 years ago
Cleaning a Vial Filling Lineabout 11 years ago
Establishing Limits for Dermal Absorption of Elemental Impuritiesabout 11 years ago
A Matter of Tasteabout 11 years ago
CMOs Concerned With Cost of Single-Use Equipmentabout 11 years ago
Manufacturers Face Key Policy and Regulatory Challengesabout 11 years ago
Getting Flexible with Manufacturingabout 11 years ago
Computerized Systems Validationabout 11 years ago
Collaborating on GMP Inspectionsabout 11 years ago
Going Low TemperatureAdvertisement
Related to this article
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
3
PharmTech Weekly Roundup—September 18, 2026
4
Introducing the "PharmTech AI Pulse Check" Expert Video Series
5